Most active drug delivery dealmakers since 2000
The leading drug delivery partnering resources
In Drug Delivery Partnering Agreements in Pharma and Biotech, the available contracts are listed by:
Stage of development at signing
Deal component type
Specific therapy target
Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.
Chapter 1 - Introduction
Chapter 2 - Overview of drug delivery dealmaking
2.2. The anatomy of drug delivery partnering
2.3. Drug delivery or specialty pharma?
2.3.1. Is specialty pharma the only way for drug delivery?
2.3.2. Best practice for optimizing drug delivery program development
2.2.3. The anatomy of a drug delivery deal
2.2.3.a. Case study 1: Alpharma - Durect - September 2008
2.2.3.b. Case study 2: Bayer - MDRNA - August 2007
2.2.3.c. Case study 3: Aradigm - Lung Rx - August 2007
Chapter 3 - Trends in drug delivery dealmaking
3.2. Drug delivery partnering since 2000
3.3. Most active drug delivery dealmakers
3.4. Bigpharma drug delivery dealmaking activity
3.5. Bigpharma not active in drug delivery
3.6. Drug delivery partnering by deal type
3.6.1. Option and evaluation drug delivery partnering
3.7. Drug delivery partnering by disease type
3.8. Drug delivery M&A activity since 2000
Chapter 4 - Leading drug delivery deals
4.2. Top drug delivery deals by value
4.3. Top drug delivery involving bigpharma
Copyright©2009 PR Newswire.
All rights reserved